You are here

Genetic variants in RBFOX3 are associated with sleep latency.

TitleGenetic variants in RBFOX3 are associated with sleep latency.
Publication TypeJournal Article
Year of Publication2016
AuthorsAmin, N, Allebrandt, KV, van der Spek, A, Müller-Myhsok, B, Hek, K, Teder-Laving, M, Hayward, C, Esko, T, van Mill, JG, Mbarek, H, Watson, NF, Melville, SA, Del Greco, FM, Byrne, EM, Oole, E, Kolcic, I, Chen, T-H, Evans, DS, Coresh, J, Vogelzangs, N, Karjalainen, J, Willemsen, G, Gharib, SA, Zgaga, L, Mihailov, E, Stone, KL, Campbell, H, Brouwer, RWw, Demirkan, A, Isaacs, A, Dogas, Z, Marciante, KD, Campbell, S, Borovecki, F, Luik, AI, Li, M, Hottenga, JJ, Huffman, JE, van den Hout, MCgn, Cummings, SR, Aulchenko, YS, Gehrman, PR, Uitterlinden, AG, Wichmann, H-E, Müller-Nurasyid, M, Fehrmann, RSn, Montgomery, GW, Hofman, A, Kao, WHL, Oostra, BA, Wright, AF, Vink, JM, Wilson, JF, Pramstaller, PP, Hicks, AA, Polasek, O, Punjabi, NM, Redline, S, Psaty, BM, Heath, AC, Merrow, M, Tranah, GJ, Gottlieb, DJ, Boomsma, DI, Martin, NG, Rudan, I, Tiemeier, H, van IJcken, WFj, Penninx, BW, Metspalu, A, Meitinger, T, Franke, L, Roenneberg, T, van Duijn, CM
JournalEur J Hum Genet
Volume24
Issue10
Pagination1488-95
Date Published2016 Oct
ISSN1476-5438
Abstract<p>Time to fall asleep (sleep latency) is a major determinant of sleep quality. Chronic, long sleep latency is a major characteristic of sleep-onset insomnia and/or delayed sleep phase syndrome. In this study we aimed to discover common polymorphisms that contribute to the genetics of sleep latency. We performed a meta-analysis of genome-wide association studies (GWAS) including 2 572 737 single nucleotide polymorphisms (SNPs) established in seven European cohorts including 4242 individuals. We found a cluster of three highly correlated variants (rs9900428, rs9907432 and rs7211029) in the RNA-binding protein fox-1 homolog 3 gene (RBFOX3) associated with sleep latency (P-values=5.77 × 10(-08), 6.59 × 10(-)(08) and 9.17 × 10(-)(08)). These SNPs were replicated in up to 12 independent populations including 30 377 individuals (P-values=1.5 × 10(-)(02), 7.0 × 10(-)(03) and 2.5 × 10(-)(03); combined meta-analysis P-values=5.5 × 10(-07), 5.4 × 10(-07) and 1.0 × 10(-07)). A functional prediction of RBFOX3 based on co-expression with other genes shows that this gene is predominantly expressed in brain (P-value=1.4 × 10(-316)) and the central nervous system (P-value=7.5 × 10(-)(321)). The predicted function of RBFOX3 based on co-expression analysis with other genes shows that this gene is significantly involved in the release cycle of neurotransmitters including gamma-aminobutyric acid and various monoamines (P-values<2.9 × 10(-11)) that are crucial in triggering the onset of sleep. To conclude, in this first large-scale GWAS of sleep latency we report a novel association of variants in RBFOX3 gene. Further, a functional prediction of RBFOX3 supports the involvement of RBFOX3 with sleep latency.</p>
DOI10.1038/ejhg.2016.31
Alternate JournalEur. J. Hum. Genet.
PubMed ID27142678
PubMed Central IDPMC5027680